In immunotherapy it is hypothesized that, due to the systemic inflammation initiated by the tumor itself, the increased infiltration of neutrophils promotes cancer progression via secreting interleukin-10 (IL-10), tumor necrosis factor α (TNF-α), and VEGF [104, 106]. Here, IL10 is linked to neoplasm.